430 related articles for article (PubMed ID: 31638474)
1. Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart.
Li H; Fan J; Zhao Y; Zhang X; Dai B; Zhan J; Yin Z; Nie X; Fu XD; Chen C; Wang DW
Circ Res; 2019 Dec; 125(12):1106-1120. PubMed ID: 31638474
[TBL] [Abstract][Full Text] [Related]
2. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.
Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827
[TBL] [Abstract][Full Text] [Related]
3. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα.
Yin Z; Zhao Y; He M; Li H; Fan J; Nie X; Yan M; Chen C; Wang DW
Cardiovasc Diabetol; 2019 Jan; 18(1):7. PubMed ID: 30635067
[TBL] [Abstract][Full Text] [Related]
4. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.
Xie SY; Liu SQ; Zhang T; Shi WK; Xing Y; Fang WX; Zhang M; Chen MY; Xu SC; Fan MQ; Li LL; Zhang H; Zhao N; Zeng ZX; Chen S; Zeng XF; Deng W; Tang QZ
Circulation; 2024 Feb; 149(9):684-706. PubMed ID: 37994595
[TBL] [Abstract][Full Text] [Related]
5. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
[TBL] [Abstract][Full Text] [Related]
6. miR-340-5p Mediates Cardiomyocyte Oxidative Stress in Diabetes-Induced Cardiac Dysfunction by Targeting Mcl-1.
Zhu Y; Yang X; Zhou J; Chen L; Zuo P; Chen L; Jiang L; Li T; Wang D; Xu Y; Li Q; Yan Y
Oxid Med Cell Longev; 2022; 2022():3182931. PubMed ID: 35126811
[TBL] [Abstract][Full Text] [Related]
7. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy.
Ni T; Lin N; Lu W; Sun Z; Lin H; Chi J; Guo H
Cardiovasc Drugs Ther; 2020 Jun; 34(3):291-301. PubMed ID: 32212062
[TBL] [Abstract][Full Text] [Related]
8. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.
Yildirim SS; Akman D; Catalucci D; Turan B
Cell Biochem Biophys; 2013; 67(3):1397-408. PubMed ID: 23723006
[TBL] [Abstract][Full Text] [Related]
9. p53 promotes cardiac dysfunction in diabetic mellitus caused by excessive mitochondrial respiration-mediated reactive oxygen species generation and lipid accumulation.
Nakamura H; Matoba S; Iwai-Kanai E; Kimata M; Hoshino A; Nakaoka M; Katamura M; Okawa Y; Ariyoshi M; Mita Y; Ikeda K; Okigaki M; Adachi S; Tanaka H; Takamatsu T; Matsubara H
Circ Heart Fail; 2012 Jan; 5(1):106-15. PubMed ID: 22075967
[TBL] [Abstract][Full Text] [Related]
10. Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation.
Wu M; Tan J; Cao Z; Cai Y; Huang Z; Chen Z; He W; Liu X; Jiang Y; Gao Q; Deng B; Wang J; Yuan W; Zhang H; Chen Y
Redox Biol; 2024 Jul; 73():103184. PubMed ID: 38718533
[TBL] [Abstract][Full Text] [Related]
11. Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice.
Zheng D; Ma J; Yu Y; Li M; Ni R; Wang G; Chen R; Li J; Fan GC; Lacefield JC; Peng T
Diabetologia; 2015 Aug; 58(8):1949-58. PubMed ID: 25994075
[TBL] [Abstract][Full Text] [Related]
12. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling.
Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
[TBL] [Abstract][Full Text] [Related]
15. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression.
Qi Y; Zhu Q; Zhang K; Thomas C; Wu Y; Kumar R; Baker KM; Xu Z; Chen S; Guo S
Circ Heart Fail; 2015 Jan; 8(1):198-208. PubMed ID: 25477432
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy.
Li X; Du N; Zhang Q; Li J; Chen X; Liu X; Hu Y; Qin W; Shen N; Xu C; Fang Z; Wei Y; Wang R; Du Z; Zhang Y; Lu Y
Cell Death Dis; 2014 Oct; 5(10):e1479. PubMed ID: 25341033
[TBL] [Abstract][Full Text] [Related]
17. Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice.
Diao X; Shen E; Wang X; Hu B
Mol Med Rep; 2011; 4(4):633-40. PubMed ID: 21584493
[TBL] [Abstract][Full Text] [Related]
18. miR-200b Mediates Endothelial-to-Mesenchymal Transition in Diabetic Cardiomyopathy.
Feng B; Cao Y; Chen S; Chu X; Chu Y; Chakrabarti S
Diabetes; 2016 Mar; 65(3):768-79. PubMed ID: 26718496
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.
Tang Q; Len Q; Liu Z; Wang W
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29288528
[TBL] [Abstract][Full Text] [Related]
20. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]